Buprenorphine Implant Clears FDA; Next Step Is Winning Patients And Physicians
This article was originally published in The Pink Sheet Daily
Executive Summary
Titan/Braeburn's Probuphine has restricted labeling, implantation risks and health care provider certification requirements, but 2,200 physicians have already signed up for training sessions.